Nouvelle autorisation pour le traitement HER2

Pour les patientes atteintes de cancer du sein HER2 positif au stade précoce, un nouveau traitement est désormais disponible. Le traitement néoadjuvant, qui prévoit la combinaison de deux anticorps et d'une chimiothérapie, promet de meilleurs résultats.
› weiterlesen

Un nouveau traitement contre le cancer du sein agressif

Il existe un nouveau traitement pour les patientes atteintes de cancer du sein HER2 positif : un traitement préopératoire associant deux anticorps. À deux ans de l'autorisation européenne, Swissmedic a désormais autorisé ce schéma thérapeutique pour la Suisse.
› weiterlesen

Radiothérapie postopératoire

Radiation therapy after breast cancer surgery is crucial to successful treatment.
› weiterlesen

L'anémie – un effet secondaire fréquent de la chimiothérapie

"About 65% of breast cancer patients develop mild to severe anemia due to illness or chemotherapy," says Dr. Veronika Pasquinelli, a hospital specialist at the Inselspital in Bern. The consequences are mainly depletion states that can result in the so-called "cancer fatigue syndrome".
› weiterlesen

Une maladie sans visage

We think very little about breast cancer: in the metastatic stage, breast cancer is almost never curable. This situation affects a large number of women, of whom there is very little talk: women over 50.
› weiterlesen

Des avancées dans la reconstruction immédiate du sein

After a mastectomy, each woman has a number of options for immediate reconstruction of her breast. The greatest advances were made in the autologous reconstruction, with tissues of the patient.
› weiterlesen
UNTERNEHMENSBEITRAG

«Vraiment satisfaites de tout le procédé»

In most cases, it is in the tumor bed that the success or failure of a breast cancer operation is decided. After the excision of the tumor, the risk of restarting the tumor is greatest in the transition zone between the affected tissues and the healthy tissues. It is for this reason that radiotherapy exactly targets this area of ??the breast. Most of the time, however, conventional radiotherapy takes place several weeks after the procedure itself: the tumor bed is often not precisely achieved. With INTRABEAM, Carl Zeiss's new irradiation device, irradiation is possible directly after the operation. Early studies have shown that the risk of relapse is extremely low.
› weiterlesen

Des fleurets et des chevaux de Troie contre le cancer du sein HER2 positif

Active substances and treatments are always more ingenious against advanced HER-2 positive breast cancer. We discussed with Prof. Dr. med. Beat ThĂĽrlimann, Chief Medical Officer and Director of the Breast Center of the St. Gallen Cantonal Hospital, the latest treatment recommendations and the hopes of research for years to come.
› weiterlesen

Radiothérapie peropératoire (IORT)

At least part of the breast radiotherapy can already be performed during the operation.
› weiterlesen

Vivre avec des métastases osseuses

> weiterlesen

Un nouveau traitement contre le cancer du sein agressif

> weiterlesen